undamentalytics Newsletter

Beyondspring Inc. key statistics and ratios

In fiscal 2022, Beyondspring Inc. had an operating margin of -2756.4% and a current ratio of 5.24. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Beyondspring Inc.: financial ratios, annual
Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Operating margin——————<−999%<−999%<−999%————
Net margin——————<−999%<−999%<−999%————
Free-cash-flow margin——————<−999%<−999%<−999%————
Return on equity——−113.8%———−102.8%−111.6%—————
Return on assets—−72.7%−92.8%−384.5%−275.1%−147.6%−75.5%−64.6%−52.1%−59.2%−37.6%−3.3%−33.0%
Asset turnover——————0.000.010.02————
Current ratio—8.345.646.750.364.068.244.965.242.312.601.540.70
Debt to equity—0.0%0.0%0.0%—4.7%2.5%5.9%—————
Interest cover (operating income ÷ interest)n/mn/m———n/mn/mn/mn/m————
R&D as % of revenue——————>999%>999%>999%————
SG&A as % of revenue——————>999%>999%962.8%————
Capital spending as % of revenue——————28.9%210.5%2.5%————

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Beyondspring Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Beyondspring Inc.